Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Joshua Sabari, an assistant professor within the Division of Medication at NYU Grossman College of Medication and director of Excessive Reliability...
In a quickly evolving oncology panorama, continued innovation is reworking remedy throughout all most cancers varieties. To achieve perception into ongoing analysis...
For Maureen Inexperienced, scalp cooling was an important a part of her breast most cancers remedy journey, because it prevented chemotherapy-induced hair...
